Comprehensive Analysis of KCNJ14 Potassium Channel as a Biomarker for Cancer Progression and Development.

ABSTRACT: Cancer is a global epidemic that has affected millions of lives. Discovering novel cancer targets is widely viewed as a key step in developing more effective therapies for cancer and other fatal illnesses. More recently, potassium (K⁺) channels have been studied as a potential biological target for the creation of cancer treatments. Potassium Inwardly Rectifying Channel Subfamily J Member 14 (KCNJ14) is one of the cancer genome's least investigated genes. This study conducted a comprehensive examination of the relationships between KCNJ14 gene expression analysis, survival, RNA modification, immunotherapy participation, and cancer stemness using several databases. KCNJ14 was shown to be dysregulated in a variety of cancers, including lung, intestinal, head and neck, oesophageal,

SUBMITTER: Alasiri G 

PROVIDER: S-EPMC9916715 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature